famotidine has been researched along with Chronic Esophagitis, Eosinophilic in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Odiase, E | 1 |
| Zhang, X | 1 |
| Chang, Y | 1 |
| Nelson, M | 1 |
| Balaji, U | 1 |
| Gu, J | 1 |
| Zhang, Q | 1 |
| Pan, Z | 1 |
| Spechler, SJ | 1 |
| Souza, RF | 1 |
1 other study available for famotidine and Chronic Esophagitis, Eosinophilic
| Article | Year |
|---|---|
In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
Topics: Biological Transport; Boron Compounds; Calcium; Calcium Channel Blockers; Cell Line; Chemokine CCL26 | 2021 |